Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 83

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 83
---
6,388,994

    General and administrative

    6,779,515

    6,839,596

    Legal expenses

    6,571,689

    15,910,480

    Reserve for credit losses and other expenses

    5,250,000

    1,300,000

    Total operating expenses

    26,277,520

    30,439,070

    Loss from operations

    (25,717,160
    )

    (29,479,667
    )

    Interest expense

    (283,042
    )

    (631,137
    )

    Other income, net

    1,005,925

    86,990

    Net loss
     
    $
    (24,994,277
    )
     
    $
    (30,023,814
    )

    Net loss per share, basic and diluted
     
    $
    (0.70
    )
     
    $
    (0.77
    )

    Weighted average shares outstanding, basic and diluted

    35,929,446

    38,793,018

The accompanying notes are an integral part of these financial statements. 

100

HCW Biologics Inc.

Statements of Changes in Stockholders’ Equity (Deficit)

    Stockholders’ Equity (Deficit)

    Common Stock

    AdditionalPaid-In

    Accumulated

    TotalStockholders’

    Shares

    Amount

    Capital

    Deficit

    Equity (Deficit)

    Balance, January 1, 2023

    35,876,440

    $
    3,588

    $
    82,962,964

    $
    (45,538,046
    )
     
    $
    37,428,506

    Issuance of Class A   Common Stock upon   exercise of stock options

    148,664

    15

    23,724

    —

    23,739

    Stock-based compensation

    —

    —

    1,003,749

    —

    1,003,749

    Net loss

    —

    —

    —

    (24,994,277
    )

    (24,994,277
    )

    Balance, December 31, 2023

    36,025,104